Stéphane Bancel is more than ever under pressure, while the South African variant of Covid-19, Omicron, particularly contagious, has been sowing panic on the planet for several days. After having succeeded in the incredible gamble of developing a vaccine in record time, from 2020, using revolutionary messenger RNA technology, after having shipped 700 million doses worldwide in 2021, Moderna is was about to move up a gear by producing up to 3 billion vaccines in 2022.
"I do not know of any other industry which has had to make such an extraordinary rise in such a short time",
recently congratulated the 49-year-old CEO.
And now the Omicron variant demonstrates what many feared: even vaccinated, humans remain under the threat of surprise and multiple mutations of the coronavirus such as those characterizing Omicron.
Read also
Covid-19: Moderna will set up a first vaccine plant in Africa
In an interview with the
Financial Times
this week, Stéphane Bancel also confided to fear
This article is for subscribers only.
You have 77% left to discover.
To cultivate one's freedom is to cultivate one's curiosity.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in
